Vann Equity Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Vann Equity Management's AZN Position: Q3 2026 in Review
Vann Equity Management increased its AstraZeneca (AZN) stake by 2.4% in Q3 2026, buying an estimated $5K and bringing the position to 1,266 shares worth $204K. The position accounts for 0.12% of the portfolio, ranked #169.
Vann Equity Management first reported a position in AZN in Q1 2026 and has held it in 3 quarters since. The position peaked at $241K in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Vann Equity Management held 1,266 shares of AstraZeneca worth $204K as of Q3 2026.
- Vann Equity Management bought 30 AstraZeneca shares in Q3 2026, an estimated $5K.
- AstraZeneca made up 0.12% of Vann Equity Management's portfolio in Q3 2026, its #169 holding.
- Vann Equity Management first reported a position in AstraZeneca in Q1 2026 and has held it in 3 quarters since.
- Vann Equity Management's AstraZeneca position peaked at $241K in Q1 2026.
- 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Vann Equity Management's 13F filing for Q3 2026, filed 8 Oct 2026.